-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Elicio Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2020 to Q2 2024.
- Elicio Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was -0.64 USD/shares, a 75.5% increase year-over-year.
- Elicio Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2024 was 18.6 USD/shares.
- Elicio Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -6.96 USD/shares, a 92.2% increase from 2022.
- Elicio Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -89.3 USD/shares, a 4525% decline from 2021.
- Elicio Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -1.93 USD/shares, a 64.5% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)